The Burden of Type 1 and Type 2 Diabetes Among Adolescents and Young Adults in 24 Western European Countries, 1990–2019: Results From the Global Burden of Disease Study 2019 Benedetta Armocida 1,2 , Lorenzo Monasta 3 *, Susan M. Sawyer 4 , Flavia Bustreo 5 , Graziano Onder 6,7 , Giulio Castelpietra 8 , Flavia Pricci 2 , Valentina Minardi 9 , Claudia Giacomozzi 2 , Cristiana Abbafati 10 , Lauryn K. Stafford 11 , Maja Pasovic 11 , Simon I. Hay 11,12 , Kanyin Lian Ong 11 , Pablo Perel 13 , David Beran 14 and GBD 2019 Europe Adolescent Diabetes 1 Division of Tropical and Humanitarian Medicine, University of Geneva, Geneva, Switzerland, 2 Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy, 3 Institute for Maternal and Child Health—IRCCS Burlo Garofolo, Trieste, Italy, 4 Department of Paediatrics, Murdoch Children’s Research Institute, Centre for Adolescent Health, Royal Children’s Hospital Melbourne, University of Melbourne, Melbourne, VIC, Australia, 5 Fondation Botnar, Geneva, Switzerland, 6 Fondazione Policlinico Gemelli IRCCS, Rome, Italy, 7 Department of Geriatric and Orthopedic Sciences, Università Cattolica del Sacro Cuore, Rome, Italy, 8 Outpatient and Inpatient Care Service, Central Health Directorate, Trieste, Italy, 9 National Centre for Disease Prevention and Health Promotion, Istituto Superiore di Sanità, Rome, Italy, 10 Department of Juridical and Economic Studies, Sapienza University of Rome, Rome, Italy, 11 Institute for Health Metrics and Evaluation, Seattle, WA, United States, 12 Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, United States, 13 Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom, 14 Division of Tropical and Humanitarian Medicine, University of Geneva and Geneva University Hospitals, Geneva, Switzerland Objectives: As little is known about the burden of type 1 (T1DM) and type 2 diabetes (T2DM) in adolescents in Western Europe (WE), we aimed to explore their epidemiology among 10–24 year-olds. Methods: Estimates were retrieved from the Global Burden of Diseases Study (GBD) 2019. We reported counts, rates per 100,000 population, and percentage changes from 1990 to 2019 for prevalence, incidence and years lived with disability (YLDs) of T1DM and T2DM, and the burden of T2DM in YLDs attributable to high body mass index (HBMI), for 24 WE countries. Results: In 2019, prevalence and disability estimates were higher for T1DM than T2DM among 10–24 years old adolescents in WE. However, T2DM showed a greater increase in prevalence and disability than T1DM in the 30 years observation period in all WE countries. Prevalence increased with age, while only minor differences were observed between sexes. Edited by: Licia Iacoviello, Mediterranean Neurological Institute Neuromed (IRCCS), Italy Reviewed by: Augusto Di Castelnuovo, Clinica Mediterranea, Italy One reviewer who chose to remain anonymous *Correspondence Lorenzo Monasta, lorenzo.monasta@burlo.trieste.it Received: 09 August 2023 Accepted: 18 December 2023 Published: 14 February 2024 Citation: Armocida B, Monasta L, Sawyer SM, Bustreo F, Onder G, Castelpietra G, Pricci F, Minardi V, Giacomozzi C, Abbafati C, Stafford LK, Pasovic M, Hay SI, Ong KL, Perel P, Beran D and GBD 2019 Europe Adolescent Diabetes (2024) The Burden of Type 1 and Type 2 Diabetes Among Adolescents and Young Adults in 24 Western European Countries, 1990–2019: Results From the Global Burden of Disease Study 2019. Int J Public Health 68:1606491. doi: 10.3389/ijph.2023.1606491 Int J Public Health | Owned by SSPH+ | Published by Frontiers February 2024 | Volume 68 | Article 1606491 1 International Journal of Public Health ORIGINAL ARTICLE published: 14 February 2024 doi: 10.3389/ijph.2023.1606491